ANXA2 and breast cancer: In our study, we also revealed that the overexpression of ANXA2 could rescue the proliferative ability of mtiRL‐KD Cd‐SV‐HUC‐1 cells and that the level of p‐ANXA2‐Y24 was high, correlating with poor prognosis in BC, suggesting that p‐ANXA2‐Y24 facilitates BC development.